Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
30 participants
INTERVENTIONAL
2016-03-15
2016-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the aims of the present study are to evaluate the effects of 10x 20min CP cataplasm application as a single treatment or in combination with electrical stimulation and massage on selected functional and molecular parameters on i) healthy subjects and ii) subjects suffering from low back pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cayenne Pepper Cataplasm - Effect Study
NCT02705209
A Human Experimental Model for Neuropathic Pain Using Combined Application of Capsaicin and Local Anesthetics
NCT01540877
Motor Unit Abnormalities After Experimentally Induced Sensitization
NCT04361149
Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
NCT02441660
Capsaicin-induced Muscle Pain in Humans
NCT02377180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the aims of the present study are firstly to evaluate the effects of 10x 20min CP cataplasm application on selected functional and molecular parameters on healthy subjects. Then, the same applications will be used on subjects suffering from low back pain (LBP) - both as a single treatment and in combination with electrical stimulation and massage.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Healthy participants with no low back pain. 20 min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical) on the back will be administered.
Cayenne Pepper topical
20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water
LBP patients - CPC Group
Participants suffering from low back pain (LBP) receiving 10 times (within 3 weeks) 20min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical).
Cayenne Pepper topical
20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water
LBP patients - CPC and ES/M Group
Participants suffering from low back pain (LBP) receiving 10 times (within 3 weeks) 20min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical), and half of the subject also receiving 10 min electrical Stimulation and 10 min massage Treatment on the back.
Cayenne Pepper topical
20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water
Electrical stimulation
Electrical stimulation 10min 60Hz biphasic rectangular neuromuscular electrical Stimulation (NMES)
Massage
10 minutes of classical massage of low back pain area.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cayenne Pepper topical
20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water
Electrical stimulation
Electrical stimulation 10min 60Hz biphasic rectangular neuromuscular electrical Stimulation (NMES)
Massage
10 minutes of classical massage of low back pain area.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index below 35 kg/mˇ2
Exclusion Criteria
* sensibility disorders (e.g. due to neurological disease)
* injuries, open wounds or rash in intervention area
* known hypersensitivity against the applied substances
* HIV, Hepatitis C and other due blood communicable infectious diseases
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
S2P, Science to Practice, Ltd.
OTHER
Comenius University
OTHER
Wilhelminenspital Vienna
OTHER
Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation
OTHER
University of Primorska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nejc Sarabon
Dean of Faculty
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nejc Šarabon, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Health Sciences, University of Primorska, Slovenia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Facultiy of Physical Education and Sports, Comenius University of Bratislava
Bratislava, , Slovakia
Faculty of Health Sciences
Izola, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UP-MunariStudy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.